In Vitro and In Vivo Evaluation of Oral Controlled Release Formulation of BCS Class I Drug Using Polymer Matrix System
Diltiazem hydrochloride is a calcium channel blocker, which belongs to the family of benzothiazepines. It is commonly used to treat hypertension and atrial fibrillation. Even though the drug has high solubility, its high permeability and rapid metabolism in the liver can limit the bioavailability an...
Saved in:
Main Authors: | Mosab Arafat (Author), Muhammad Sarfraz (Author), Mohammad F. Bostanudin (Author), Anna Esmaeil (Author), Aisha Salam (Author), Salahdein AbuRuz (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development and In Vitro Evaluation of Controlled Release Viagra<sup>®</sup> Containing Poloxamer-188 Using Gastroplus<sup>™</sup> PBPK Modeling Software for In Vivo Predictions and Pharmacokinetic Assessments
by: Mosab Arafat, et al.
Published: (2021) -
Effect of Hydration Forms and Polymer Grades on Theophylline Controlled-Release Tablet: An Assessment and Evaluation
by: Molham Sakkal, et al.
Published: (2024) -
Effect of Excipients on the Quality of Drug Formulation and Immediate Release of Generic Metformin HCl Tablets
by: Mosab Arafat, et al.
Published: (2023) -
Nanomedicines: Emerging Platforms in Smart Chemotherapy Treatment-A Recent Review
by: Mosab Arafat, et al.
Published: (2024) -
Nanosized Liposomes Containing Bile Salt: A Vesicular Nanocarrier for Enhancing Oral Bioavailability of BCS Class III Drug
by: Mosab Arafat, et al.
Published: (2017)